J&J, Boston Scientific Break Even in Patent DisputesJ&J, Boston Scientific Break Even in Patent Disputes
A federal judge has upheld two separate jury verdicts involving stent patents. One found Johnson & Johnson in violation of a Boston Scientific patent, and one found Boston Scientific in violation of a J&J patent, the Associated Press reports. J&J is appealing the ruling against it, which means it will probably be a while before compensation or damages payments are decided.
May 12, 2006
1 Min Read
Much is at stake here, as J&J's Cypher and Boston Scientific's Taxus drug-eluting stents are the best-selling medical devices on the market.
Sign up for the QMED & MD+DI Daily newsletter.
You May Also Like